Direct Biologics
TX - Austin
BiotechnologyFocus: Allografts
Direct Biologics is a life sciences company focused on Allografts.
Infectious DiseasesImmunologyRespiratoryOphthalmology
Open Jobs
1
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT05215288Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients
N/AExoFlo
Covid19Clinical Trials (1)
NCT04657458Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS
N/AExoFlo
Crohn DiseaseClinical Trials (1)
NCT05130983Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease
Phase 1ExoFlo
Ulcerative ColitisClinical Trials (1)
NCT05176366Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis
Phase 1ExoFlo
Perianal FistulaClinical Trials (1)
NCT05836883Study of ExoFlo for the Treatment of Perianal Fistulas
Phase 1/2Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles
Covid19Clinical Trials (1)
NCT05116761ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome
Phase 1/2Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles
ARDS, HumanClinical Trials (1)
NCT05127122Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS
Phase 1/2ExoFlo
COVID-19Clinical Trials (1)
NCT05125562Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19
Phase 2Phase 2
Clinical Trials (1)
NCT06918808DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
Phase 2ExoFlo
COVID-19Clinical Trials (1)
NCT04493242Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
Phase 2Phase 3
Clinical Trials (1)
NCT05354141Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Phase 3Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 11 clinical trials
Open Roles: 1 active job
Hiring Trend
Stable
1
Open Roles
+0
Added
-1
Filled/Removed
Based on last 4 crawl cycles